Table 1.
IBD Group (n=52) |
Control Group (n=37) |
P-value | |
---|---|---|---|
Age (y) | 49.2±11.4 | 45.5±10.1 | 0.117 |
Sex, female | 27 (51.9) | 22 (59.4) | 0.625 |
Active smoking | 2 (3.8) | 6 (16.2) | 0.062 |
Diabetes | 7 (13.5) | 3 (8.1) | 0.513 |
High blood pressure | 8 (15.4) | 6 (16.2) | 0.850 |
Dyslipidemia | 2 (3.8) | 5 (13.5) | 0.122 |
Systolic blood pressure (mmHg) Diastolic blood pressure (mmHg) |
12 (11 - 13) 8 (7 - 9) |
12 (11.5 - 13) 8 (7 - 8) |
0.897 0.927 |
Total cholesterol (mg/dL) | 188±43 | 195±37 | 0.434 |
HDL-cholesterol (mg/dL) | 47.5 (39 - 59) | 46 (41 - 53.5) | 0.683 |
LDL-cholesterol (mg/dL) | 108±37 | 119±27.6 | 0.136 |
Fasting glucose (mg/dL) | 95 (86.2 - 107.3) | 86 (79 - 100) | 0.041 |
Triglycerides (mg/dL) | 126.5 (89.5 - 181.5) | 123 (89 - 182) | 0.930 |
Carotid intima-media thickness (mm) | 0.69±0.12 | 0.63±0.12 | 0.031 |
Presence of atherosclerotic plaque | 13 (25) | 2 (5.4) | 0.032 |
Moderate and high cardiovascular risk according to the Framingham risk score | 16 (30.8) | 5 (13.5) | 0.102 |
Note: Data expressed as n (%), mean±SD, or median and quartiles (Q1–Q3).
Abbreviations: HDL-cholesterol, high-density lipoprotein cholesterol; LDL-cholesterol, low-density lipoprotein cholesterol.